Mechanism of transcriptional activation of the immediate early gene Egr- 1 in response to PIXY321

Blood

Volumn 88, Issue 3, 1996, Pages 848-854

  Mignacca, Robert C ^b   Lee, Hu Jung Julie ^b   Kwon, Evelyn M ^b   Sakamoto, Kathleen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMMEDIATE EARLY PROTEIN; IMMEDIATE EARLY PROTEIN EGR 1; INTERLEUKIN 3; MILODISTIM; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; ELECTROPHORETIC MOBILITY; GENE ACTIVATION; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; IMMUNOBLOTTING; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0029680633     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.3.848.bloodjournal883848     Document Type: Article

References (24)

1. Gerhartz HH, Engelhard M, Meusers P, Brittinger G, Wilmanns W, Schlimok G, Mueller P, Huhn D, Musch R, Siegert W, Gerhartz D, Hartlapp JH, Thiel E, Huber C, Peschl C, Spann W, Emmerich B, Schadek C, Westerhausen M, Pees H-W, Radtke H, Engert A, Terhardt E, Schick H, Binder T, Fuchs R, Hasford J, Brandmaier R, Stern AC, Jones TC, Ehrlich HJ, Stein H, Parwaresch M, Tiemann M, Lennert K: Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas. Blood 82:2329, 1993
2. Rowe JM, Andersen J, Mazza JJ, Paietta E, Bennett JM, Hayes A, Oette D, Wiernik PH: Phase III randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor (GM-CSF) in adult patients (55-70 years) with acute myelogenous leukemia (AML). A study of the Eastern Cooperative Oncology Group (ECOG). Blood 82:329a, 1993 (suppl 1)
3. Ganser A, Lindemann A, Seipelt G, Ottman OG, Herrmann F, Eder M, Frisch J, Schulz G, Mertelsmann R, Hoelzer D: Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure. Blood 76:666, 1990
4. Ganser A, Lindemann A, Seipelt G, Ottman OG, Herrmann F, Eder M, Frisch J, Schulz G, Mertelsmann R, Hoelzer D: Clinical effects of recombinant human interleukin-3. Am J Clin Oncol 14:S51, 1991
5. Williams DE, Park LS: Hematopoietic effects of a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein. Cancer 67:2705, 1991
6. Curtis BM, Williams DE, Broxmeyer HE, Dunn J, Farrah T, Jeffery E, Clevenger W, DeRoos P, Martin U, Friend D, Craig V, Gayle R, Price V, Cosman D, March C, Park LS: Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein. Proc Natl Acad Sci USA 88:5809, 1991
7. Vadhan-Raj S, Papadopoulos NE, Burgess MA, Linke KA, Patel SR, Hays C, Arcenas A, Plager C, Kudelka AP, Hittelman WN, Broxmeyer HE, Williams DE, Garrison L, Benjamin RS: Effects of PIXY321, a granulocyte-macrophage colony stimulating factor interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma. J Clin Oncol 12:715, 1994
8. Runowicz CD, Mandeli J, Speyer J, Wadler S, Cohen C, Hochster H, Bruckner H, Goldberg G, Smith H, Garrison L, Wallach R, Tomaino C, Demakos E, Sorich J, Holland JF: Phase I/II study of PIXY321 in combination with cyclophosphamide (CTX) and carboplatin (CP) in the treatment of patients (PTS) with ovarian cancer (OC). Proc Am Soc Clin Oncol 12:260, 1993 (abstr)
9. Vose JM, Anderson J, Bierman PJ, Garrison L, Appelbaum F, Anderson JR, Bishop M, Larsen K, Armitage JO: Initial trial of PIXY321 (GM-CSF/IL-3 fusion protein) following high-dose chemotherapy and autologous bone marrow transplantation (ABMT) for lymphoid malignancy. Proc Am Soc Clin Oncol 12:366, 1993 (abstr)
10. Vadhan-Raj S, Jeha S, Broxmeyer HE, Hittelman WN, Thompson P, Arcenas A, Hoots WK, Estey E, Garrison L: Stimulation of hematopoiesis by PIXY321 (GM-CSF/IL-3 fusion protein) in patients with bone marrow failure. Blood 82:366a, 1993 (suppl 1)
11. Sakamoto KM, Mignacca RC, Gasson JC: Signal transduction by granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors. Recept Channels 2:175, 1994
12. Sakamoto KM, Fraser JK, Lee H-JJ, Lehman E, Gasson JC: Granulocyte-macrophage colony-stimulating factor and interleukin-3 signaling pathways converge on the CREB-binding site in the human egr-1 promoter. Mol Cell Biol 14:5975, 1994
13. Lee H-JJ, Mignacca RC, Sakamoto KM: Transcriptional activation of Egr-1 by granulocyte-macrophage colony-stimulating factor but not interleukin-3 requires phosphorylation of cAMP response element-binding protein (CREB) on serine 133. J Biol Chem 270:15979, 1995
14. Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao Y-F, Miyazono K, Urabe A, Takaku F: Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 140:323, 1989
15. Sakamoto KM, Nimer SD, Rosenblatt JD, Gasson JC: HTLV-I and HTLV-II Tax trans-activate the human EGR-1 promoter through different cis-acting sequences. Oncogene 7:2125, 1992
16. Peterlin M, Luciw P, Barr P, Walker M: Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus. Proc Natl Acad Sci USA 83:9734, 1986
17. Gorman CM, Moffat LF, Howard BH: Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 2:1044, 1982
18. Rosenthal N: Identification of regulatory elements of cloned genes with functional assays. Methods Enzymol 152:704, 1987
19. Ginty DD, Kernhauser JM, Thompson MA, Bading H, Mayo KE, Takahashi JS, Greenberg ME: Regulation of CREB phosphorylation in the suprachiasmatic nucleus by light and a circadian clock. Science 260:238, 1993
20. Ginty DD, Bonni A, Greenberg ME: Nerve growth factor activates a Ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB. Cell 77:713, 1994
21. Treisman R: The serum response element. Trends Biochem Sci 17:423, 1992
22. Karin M, Smeal T: Control of transcription factors by signal transduction pathways: The beginning of the end. Trends Biochem Sci 17:418, 1992
23. Lee KAW: Transcriptional regulation by cAMP. Curr Opin Cell Biol 3:953, 1991
24. Montminy MR, Gonzalez GA, Yamamoto KK: Characteristics of the cAMP response unit. Recent Prog Hormone Res 46:219, 1990